Infection Outcomes in Solid Organ Transplant Recipients Receiving Trimethoprim-Sulfamethoxazole as Opposed to Atovaquone for Prophylaxis.

被引：0
|
作者：
Drelick, A. [1 ]
Mowrey, W. [2 ]
Minamoto, G. [3 ,4 ]
机构：
[1] Weill Cornell Med Ctr, Div Infect Dis, Med, New York, NY USA
[2] Albert Einstein Coll Med, Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Div Infect Dis, Med, 111 E 210th St, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C347
引用
收藏
页码：887 / 887
页数：1
相关论文
共 50 条
  • [1] Evaluation of the Incidence of Nocardia Infection in Solid Organ Transplant Recipients on Trimethoprim-Sulfamethoxazole for Opportunistic Infection Prophylaxis
    Jung, Regina
    Au, Jenny
    Burnell, Jacqueline
    Diamond, Adam
    Shah, Ishani
    Ruggia-Check, Christina
    ANNALS OF PHARMACOTHERAPY, 2024,
  • [2] Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients
    Muñoz, P
    Arencibia, J
    Rodríguez, C
    Rivera, M
    Palomo, J
    Yañez, J
    Bouza, E
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (07) : 932 - 933
  • [3] Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients - Reply
    Montoya, JG
    Remington, JS
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (07) : 933 - 933
  • [4] Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients and Role of Prophylaxis.
    Nance, G.
    Serluco, A.
    Deshpande, S.
    Garro, R.
    George, R.
    Kelleman, M.
    Liverman, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 877 - 877
  • [5] Efficacy of Trimethoprim-Sulfamethoxazole Prophylaxis for Nocardia in Solid Organ Transplant Recipients (SOTRs): Systematic Review and Meta-Analysis
    Alsharidi, A.
    Gonzalez, A.
    Rotstein, C.
    Humar, A.
    Kumar, D.
    Husain, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 547 - 547
  • [6] Pneumocystis Prophylaxis in Solid Organ Transplant Recipients at Two Large Transplant Centers from 2015-2016: Why Not Trimethoprim-Sulfamethoxazole?
    Lum, J. M.
    Athans, V.
    Echenique, I.
    Koval, C. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 729 - 729
  • [7] Duration of prophylaxis with trimethoprim-sulfamethoxazole in patients undergoing solid organ transplantation
    Malhotra, P.
    Rai, S. D.
    Hirschwerk, D.
    INFECTION, 2012, 40 (04) : 473 - 475
  • [8] TRIMETHOPRIM-SULFAMETHOXAZOLE - INFECTION PROPHYLAXIS DURING GRANULOCYTOPENIA
    WADE, J
    SCHIMPFF, S
    HARGADON, M
    BENDER, J
    AISNER, J
    YOUNG, V
    WIERNIK, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 350 - 350
  • [9] Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe Pneumocystis pneumonia in solid organ transplant recipients
    Utili, Riccardo
    Durante-Mangoni, Emanuele
    Basilico, Cristina
    Mattei, Annunziata
    Ragone, Enrico
    Grossi, Paolo
    TRANSPLANTATION, 2007, 84 (06) : 685 - 688
  • [10] TRIMETHOPRIM-SULFAMETHOXAZOLE AND TRIMETHOPRIM ALONE FOR PROPHYLAXIS OF INFECTION IN GRANULOCYTOPENIC PATIENTS
    GURWITH, M
    TRUOG, K
    HINTHORN, D
    LIU, C
    REVIEWS OF INFECTIOUS DISEASES, 1982, 4 (02): : 593 - 601
12345